Non-executive director Guo Huaqing increased his holding of Keji Pharmaceutical (02171) by 30,000 shares at a price of HK$15.09 per share.

19:26 24/12/2025

On December 19, non-executive director Guo Huaqing increased his holdings of Koji Pharmaceuticals (02171) by 30,000 shares, with a unit price of 15.09 Hong Kong dollars, for a total amount of 452,700 Hong Kong dollars.

The latest data from the Hong Kong Stock Exchange showed that on December 19, non-executive director Guo Huaqing increased his stake in Keji Pharmaceutical (02171) by 30,000 shares, priced at HK$15.09 per share, with a total amount of HK$452,700. After the increase, the latest number of shares held is approximately 226 million shares, with a shareholding percentage of 39.02%.

HK Stock Market Move | XPENG-W (09868) rose more than 6%, the company accelerating its layout in the Middle East and Africa markets, recently reaching a strategic cooperation with a well-known distributor in Mauritius.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.